NASDAQ

Werewolf Therapeutics, Inc. (HOWL)

♥ 638 Thanks from members

Live price chart, market sentiment, and community perspectives for Werewolf Therapeutics, Inc. (NASDAQ: HOWL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Peter LichtlenFounder: Ananya SundaramLeadership: Peter Lichtlen (CEO)Leadership: Kimberly Barrett (CFO)Holder: Atlas VentureHolder: ForbionHolder: Longwood FundWTX-124WTX-330PIGEN immunotherapy platform#HOWL stock#Werewolf Therapeutics#Immuno-oncology#Biotech IPO#Conditionally Active Therapeutics